Диссертация (1139499), страница 42
Текст из файла (страница 42)
– 2011. - №3. – С.71-74.154. Шварков С.Б. Вегетативный дисбаланс у больных метаболическимсиндромом: роль в развитии гиперфильтрации – раннего маркера пораженияпочек./ Шварков С.Б. [и др.]// Терапевтический архив. – 2010. - №6. - С.
49-53.155. Шварц В. Воспаление жировой ткани и атеросклероз./ Шварц В.//Кардиология.- 2009. - №13. – С.80-86.156. Шевченко О.В. Клиническое значение вариабельности сердечного ритма убольных артериальной гипертонией: автореф. дис. …канд. мед. наук./ ШевченкоО.В. – Саратов., 2008г – 24с.157. Шестопал Н.С. Особенности гемодинамики, нейрогормонального статуса иморфофункциональные характеристики почек при артериальной гипертензии умужчин молодого возраста: автореф. дис…канд.мед.наук./ Шестопал Н.С. – М.,2003.
- 21с.158. ШиловЕ.М.Нефрология.Учебноепособиедляпослевузовскогообразования./ Шилов Е.М. - М.: ГЭОТАР-Медиа, 2007. – 683с.159. Шилов Е.М. Новые подходы к лечению больных хронической болезньюпочек и метаболическим синдромом./Шилов Е.М., Леванковская Е.И., НовиковаМ.С.// Клиническая нефрология. – 2012. - №2. – С.43-48.160. Шипилова Т.
Определение массы миокарда левого желудочка и егогеометрии по данным эхокардиографии в популяционном исследовании женщинТаллина./ Шипилова Т. [и др.]// Кардиология. – 2002. - №11. – С.52-56.161. Шхвацабая И. К. Низкорениновая форма гипертонической болезни:особенностифункциональныхсоотношенийпрессорнойсистемыренин-альдостерон./Шхвацабая И.К. [и др.]// Кардиология.
– 1983. - №23(4). – С.5-10.270162. Яновская Г.Р. Функция эндотелия у молодых мужчин с эссенциальнойгипертонией./Г.Р.Яновская,В.В.Белов,А.А.Болотов//Российскийкардиологический журнал. – 2004. - №3(47). – С.21-30.163. Ярных Е.В. Артериальная гипертония у женщин в климактерическомпериоде: клинические особенности, состояние дофаминергической активности иинсулинорезистентности.Обоснованиегипотензивнойтерапии:автореф.дис…канд.мед.наук./ Ярных Е.В. - М., 2000. – 24с164. 2013 ESC guidelines on the management of stable coronary artery disease—addenda.
The Task Force on the management of stable coronary artery disease of theEuropean Society of Cardiology.// Eur Heart J. – 2013. - 32p. Режим доступа:https://www.escardio.org/static_file/Escardio/Guidelines/publications/ANGINA2013_Stable_Coronary_Artery_Disease_web_addenda.pdf - свободный165. 2013 ESH-ESC guidelines for the management of arterial hypertension. ESHESC Guidelines Committee.// J Hypertens. – 2013. – Vol.31. – Р.1281-1357.166. 2014 Evidence-based guidelines for the management of high blood pressure inadults. Report from the panel members appointed to the eight Joint National Committee(JNC 8).// JAMA. – 2014. – Vol.311(5).
– Р.507-520.167. Agarwal M. The relationship between albuminuria and hormone therapy inpostmenopausal women./ Agarwal M. [et al]// Am J Kidney Dis. – 2005. – Vol.45 (6). –Р.1019-1025.168. Akintunde AA. Gender specific pattern of left ventricular adaptation tohypertension and obesity in a tertiary healthy facility in Nigeria./ Akintunde AA,Oladosu Y, Opadijo OG.// Afr Health Sci. – 2013. – Vol.13(3). – Р. 595-600.169.
Alberti KG. The Metabolic Syndrome – A New Worldwide Definition from theInternational Diabetes Federation Consensus// Alberti KG, Zimmet PZ, Shaw JE.//Lancet. - 2005. - Vol.366. - P. 1059-62.170. Alvarez G.E. Sympathetic neural activation in visceral obesity./ Alvarez G.E.,Beske S.D., Ballard T.P. [et al]// Circulation. – 2002. – Vol.1067 – P.2533-2536.271171. Amaral SL. Exercise training nor- malizes wall-to-lumen ratio of the gracilismuscle arterioles and reduces pressure in spontaneously hypertensive rats./ Amaral SL,Zorn TM, Michelini LC. // J Hypertens. – 2000. – Vol.18.
– P.1563-1572.172. Anttila L. Serum total renin levels after ovarian electrocautery in women withpolycystic ovary syndrome./ Anttila L., [et al.]// Gynecol Endocrinol. – 1998. – Vol.12.– P.327-31.173. Aronson D. Obesity is the major determinant of elevated C–reactive protein insubjects with the metabolic syndrome./ Aronson D. [et al] // Int J Obes Relat MetabDisord. – 2004. – Vol.28(5).
– P.674–9.174. Athyros VG. The prevalence of the metabolic syndrome using the NationalCholesterol Education Program and International Diabetes Federation definitions./Athyros VG. [et al]// Curr Med Res Opin. – 2005. – Vol.21. – P.1157-9.175. Baile C.A. Regulation of metabolism and body fat mass by leptin./ Baile C.A.,Delle-Fera M.A., Martin R.J.
// Ann Rev Nutr. - 2000. – Vol.20. – P.105-27.176. Barbagallo M. Vascular effects of progesterone: role of intracellular calciummetabolism./ Barbagallo M. [et al]// Am J Hypertens. – 1995. – Vol.8(4). – P. 66A177. Baylis C. Changes in renal hemodynamics and structure in the aging kidney;sexual dimorphism and the nitric oxide system./ Baylis C.// Exp Gerontol. – 2005.
–Vol.40. – P.271–278.178. Baylis C. Sexual dimorphism in the aging kidney: differences in the nitric oxidesystem./ Baylis C. // Nat Rev Nephrol. – 2009. – Vol.5. – P. 384–396.179. Baylis C. Sexual Dimorphism: The Aging Kidney, Involvement of Nitric OxideDeficiency, and Angiotensin II Overactivity./Baylis C. // J Gerontol A Biol Sci MedSci. – 2012. – Vol.67(12). – P. 1365–1372.180. Bealer S.L.
Central Neuronal Histamine Contributes to CardiovascularRegulation./ Bealer S.L. //News in Physiol Sci. – 1999. – Vol.14. - №3. – P.100-5.181. Beltowski J. Leptin and atherosclerosis./Beltowski J.//Atherosclerosis. – 2006. –Vol.189. – P.47–60.272182. Benjamin EJ. Clinical correlates and heritability of flow-mediated dilation in thecommunity: the Framingham Heart Study./ Benjamin EJ, [et al.]// Circulation. – 2004.– Vol.109. – P.613–9.183. Berecek K.H.
Adrenergic and dopaminergic receptors and activation./ BerecekK.H., Carey R.M. // In: Hypertension primer. The essentials of high blood pressure. Ed.J.L.Izzo, and H.R.Black. Am Heart Association, 2003. – P.33-38.184. Berg UB. Differences in decline in GFR with age between males and females.Reference data on clearances of inulin and PAH in potential kidney donors./ Berg UB. //Nephrol Dial Transplant.
– 2006. – Vol.21. – P.2577-2582.185. Bi’e Tan. Regulatory roles for L-arginine in reducing white adipose tissue./ Bi’eTan. [et al].// Front Biosci. – 2012. – 17. – P.2237–2246.186. Bilsel A.S. 17Beta-estradiol modulates endothelin-1 expresion and release inhuman endothelial cells./ Bilsel A.S., et al.
// Cardiovasc Res. – 2000. – Vol.2(3). –P.579-84.187. Birch Nielsen C. Transforming growth factor beta1-induced glomerulopathy isprevented by 17beta-estradiol supplementation./ Birch Nielsen C. [et al]// VirchowsArch. – 2004. – Vol.444. – P.561-66.188. Biro J.C. Adrenomedullin expression in rat uterus is correlated with plasmaestradiol./ Biro J.C., et al. // Am J Physiol Endocrinol Met. – 2002. – Vol.282.
– P.139146.189. Biro J.C. Inhibitory effect of the uterus on plasma and pituitary FSH in rats./ BiroJ.C., Eneroth P.// J Endocrinology. – 1990. – Vol.124. – P.183-189.190. Bittner V. Women and coronary heart disease risk factors./ Bittner V. // JCardiovasc Risk. – 2002.
– Vol.9(6). – P.315-322.191. Blauwet LA. The role of sex-specific results reporting in cardiovascular disease./Blauwet LA, Redberg RF. // Cardiol Rev. – 2007. – Vol.15(6). – P.275-8.192. Brar V. Sex-specific effects of cardiovascular risk factors on endoteliumdependent dilation and endothelin activity in middle-aged women and men./ Brar V. [etal]// PLoS One. – 2015. – Vol.10(3).
– P.e0121810.273193. Bravo P. Leptin and Hypertension in Obesity/ Bravo P, [et al]. // Vasc HealthRisk Manag. - 2006. – Vol.2(2). – P.163–169.194. Brilla C.G. Aldosterone-mediated stimulation of collagen synthesis in culturedcardiac fibroblasts/ Brilla C.G., Zhou G., Weber K.T. // J Hypertens. – 1992. – Vol.10.– Р. 7.195. Brodsky SV. Endothelium under stress: local and systemic messanges./ BrodskySV, Goligorsky MS. // Semin Nephrol. – 2012.
– Vol.32(2). – P.192–198.196. Brown M.A., Chang R.J. Polycystic Ovary Syndrome: Clinical and ImagingFeatures./ Brown M.A., Chang R.J. // Ultrasound Q. – 2007. - Vol. 23. - №4. P. 233-238197. Brown MJ. Morbidity and mortality in patients randomized to double-blindtreatment with long-acting calcium-channel blocker or diuretic in InternationalNifedipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT)./Brown MJ, [et al].
// Lancet. – 2000. – Vol. 356(9228). – Р. 366-372.198. Brown N.J. Aldosterone and PAI-1: implications for renal injury./ Brown N.J.,Vanghan D.E., Fogo A.V. // J Nephrol. – 2002. – Vol. 15. - №3. – P. 230-235.199. Burns KD. Angiotensin II and its receptors in the diabetic kidney/ Burns KD. //Am J Kidney Dis. - 2000. – Vol.36(3). – P.446–467.200. Caeiro XE. Sex Chromosome Complement Contributes to Sex Differences inBradycardic Baroreflex Response/ Caeiro XE.
[et al]// Hypertension. – 2011. –Vol.58.– P.505-511.201. Campese V.M. Is microalbuminuria a predictor of cardiovascular and renaldisease in patients with essential hypertension?/ Campese V.M., Bianchi S., Bigazzi R.//Curr. Opin. Nephrol. Hypertens. – 2000. – Vol. 9. – P. 143-147.202. Canepa M. Early contribution of arterial wave reflection to left ventricularrelaxation abnormalities in a community-dwelling population of normotensive anduntreated hypertensive men and women./ Canepa M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
